Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Bristol-Myers Squibb Enters Collaboration To Leverage Foundation Medicine’s Molecular Information Platform

    Apr 3, 2017, 11:55 AM by Michael Croft

    Bio-IT World Brief | Bristol-Myers Squibb and Foundation Medicine announced a collaboration that leverages Foundation Medicine’s comprehensive genomic profiling and molecular information solutions to identify predictive biomarkers such as Tumor Mutational Burden and Microsatellite Instability in patients enrolled across clinical trials investigating Bristol-Myers Squibb’s cancer immunotherapies.

    Full story
  • Sharp announces £9 million investment

    Apr 3, 2017, 04:04 AM by Michael Croft
    RHYMNEY, UK - Apr 3, 2017 - Sharp Clinical Services (Sharp), part of UDG Healthcare plc (LON:UDG), has announced a £9 million  investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution facility in Wales
    Full story
  • Georgetown University, 10x Genomics, Jackson Laboratory, And More: News From March 2017

    Mar 30, 2017, 15:10 PM by Michael Croft

    Bio-IT World Brief | News, products, and partnerships from around the bio-IT community including news from Georgetown University, 10x Genomics, Jackson Laboratory, and more.

    Full story
  • Ethical Assessment of Clinical Trials Following EU CTR Implementation - Are We Ready for Changes?

    Mar 30, 2017, 05:16 AM by Michael Croft
    BERLIN, GERMANY - Mar 30, 2017 - Since the publication of the EU Clinical Trial Regulation (CTR) 536/2014 in the Official Journal  a new scheme of Clinical Trial Application (CTA)  has been developed
    Full story
  • Cenduit to Showcase Advanced Solutions at IRT Europe 2017

    Mar 29, 2017, 16:34 PM by Michael Croft
    DURHAM, NC, UNITED STATES - Mar 29, 2017 -  WHAT:  Cenduit, LLC, the largest interactive response technology (IRT) specialist in the world, is showcasing its solutions and expertise at IRT Europe, April 4-5 in London, England
    Full story
  • Hi-C The Game-Changing Technique That Cracked the Zika-Mosquito Genome

    Mar 29, 2017, 14:34 PM by Michael Croft
    The Atlantic | "Hi-C" will make it much easier and cheaper to assemble all of an organism's genetic material from scratch.
    Full story
  • Fabric Genomics: New Identity, Partnerships, Products for Omicia

    Mar 29, 2017, 09:20 AM by Michael Croft

    Bio-IT World | Omicia rebranded last week, relaunching itself as Fabric Genomics with new products and new partnerships.

    Full story
  • Van Andel Research Institute installs world-class microscopes to enable discovery of the molecular basis of disease

    Mar 29, 2017, 00:38 AM by Michael Croft
    GRAND RAPIDS, MI, UNITED STATES - Mar 28, 2017 - Van Andel Research Institute (VARI) is now home to one of the world’s most powerful microscopes—one that images life’s building blocks in startling clarity and equips VARI’s growing team of scientists to push the limits of discovery in search of new treatments for diseases such as cancer and Parkinson’s
    Full story
  • TECHNIDATA launches new generation TDBactiLink, the middleware for bacteriology laboratories, and dedicated website: www.microbiology-middleware.com

    Mar 28, 2017, 12:26 PM by Michael Croft
    MONTBONNOT, FRANCE - Mar 28, 2017 -   A cost-effective middleware that brings laboratories to the forefront of technology  TDBactiLink is a dedicated middleware solution for bacteriology laboratories looking to make the most of technological advances and paperless organization without changing their existing laboratory information system (LIS)
    Full story
  • Silicon Valley’s Quest to Live Forever

    Mar 28, 2017, 10:15 AM by Michael Croft
    The New Yorker | Can billions of dollars' worth of high-tech research succeed in making death optional?
    Full story
  • Linguamatics and Dow Jones Partner to Accelerate Pharma Industry Research

    Mar 28, 2017, 09:27 AM by Michael Croft
    CAMBRIDGE, UK - Mar 28, 2017 - – Market leading NLP text analytics provider Linguamatics today announced a partnership with premium news content provider Dow Jones
    Full story
  • 2017 Benjamin Franklin Award Finalists Announced

    Mar 24, 2017, 13:45 PM by Michael Croft

    Bio-IT World | Bioinformatics.org has announced five finalists for the 2017 Benjamin Franklin Award for Open Access in the Life Sciences. The winner will be announced onsite at the 2017 Bio-IT World Conference & Expo.

    Full story
  • TraceLink and Advanco partner to simplify serialization line management integration

    Mar 24, 2017, 06:33 AM by Michael Croft
    - Mar 24, 2017 - North Reading, MA (March 23, 2017)—TraceLink Inc., the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced a partnership with Advanco to support pharmaceutical manufacturers with the integration of line management and enterprise systems when complying with new serialization regulations
    Full story
  • GSK and Regeneron to mine gene data from 500000 Britons

    Mar 23, 2017, 16:33 PM by Michael Croft
    Reuters | Britain's GlaxoSmithKline and U.S.-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease.
    Full story
  • A Scholarly Sting Operation Shines a Light on ‘Predatory’ Journals

    Mar 22, 2017, 15:18 PM by Michael Croft
    The New York Times | A group of researchers created a ruse to draw attention to the seamy side of open-access journals, some of which will publish just about anything for a fee.
    Full story
  • Follow The Customer: DNAnexus On The New Wave In Bioinformatics

    Mar 22, 2017, 09:00 AM by Michael Croft

    Bio-IT World | The sequencing space has changed rapidly in the past few years, and DNAnexus has followed their customers, keeping pace with the evolution. Now CEO Richard Daly is looking forward to the next phase of company growth, this time in the cloud.

    Full story
  • Recipharm partners with Sato to manufacture product for Japanese market

    Mar 21, 2017, 13:28 PM by Michael Croft
    KARLSKOGA, SWEDEN - Mar 21, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co
    Full story
  • Eurofins to invest millions in new UK facility

    Mar 21, 2017, 13:26 PM by Michael Croft
    LIVINGSTON, SCOTLAND - Mar 21, 2017 - Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment
    Full story
  • Human Longevity Launches Whole Genome Product, MassMutual Partnerships

    Mar 20, 2017, 12:45 PM by Michael Croft

    Bio-IT World | Human Longevity, Inc. and Massachusetts Mutual Life Insurance Co. announced an agreement to offer HLI's new whole genome sequencing product, HLIQ Whole Genome, to eligible MassMutual customers, employees, and financial professionals at a reduced price.

    Full story
  • Nvidia And Bosch Team Up On Self-Driving Car AI Supercomputer

    Mar 17, 2017, 10:35 AM by Michael Croft
    TechCrunch | Nvidia's new partner in bringing AI-powered self-driving tech to the masses definitely has the experience needed to go truly mass-market - it's Bosch.
    Full story
  • «
  • 301
  • 302
  • 303
  • 304
  • 305
  • 306
  • 307
  • 308
  • 309
  • 310 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy